|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL.: (2006.01) |
A61K 45/00 A61K 31/565 A61K 31/567 A61P 5/00 |
| (11) | Number of the document | 5011 |
| (13) | Kind of document | B |
| (21) | Application number | 2002 037 |
| (22) | Date of filing the application | 2002-03-27 |
| (41) | Date of publication of the application | 2002-11-25 |
| (45) | Date of publication of patent | 2003-04-25 |
| (86) | Number | PCT/US00/23771 |
| Date | 2000-08-31 |
| (87) | Number | WO 01/34126 |
| Date | 2001-05-17 |
| (30) | Number | Date | Country code |
| 386140 | 1999-08-31 | US |
| (71) |
JENAPHARM GMBH & CO. KG,
Otto-Schott-Strasse 15, D-07745 Jena,
DE
|
| (72) |
Walter ELGER, DE
Gerd SCHUBERT, DE Kristof CHWALISZ, DE |
| (73) |
Bayer Schering Pharma Aktiengesellschaft,
Müllerstrasse 178, 13353 Berlin,
DE
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | MESOPROGESTINS (PROGESTERONE RECEPTOR MODULATORS) AS A COMPONENT OF COMPOSITIONS FOR HORMONE REPLACEMENT THERAPY (HRT) |
| Payment date | Validity (years) | Amount | |
| 2009-07-24 | 10 | 800.00 LTL |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2010-08-31 |